Literature DB >> 10391802

Long-term hepatocyte transplantation using three-dimensional matrices.

P M Kaufmann1, U Kneser, H C Fiegel, D Kluth, H Herbst, X Rogiers.   

Abstract

Mesh：

Year:  1999        PMID： 10391802     DOI： 10.1016/s0041-1345(99)00208-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Cellular therapy and bioartificial approaches to liver replacement.

Authors:  Jason A Wertheim; Pedro M Baptista; Alejandro Soto-Gutierrez
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

Review 2.  Hepatic stem cells: A viable approach for the treatment of liver cirrhosis.

Authors:  Md Aejaz Habeeb; Sandeep Kumar Vishwakarma; Avinash Bardia; Aleem Ahmed Khan
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

Review 3.  Development of hepatic tissue engineering.

Authors:  Henning Cornelius Fiegel; Ulrich Kneser; Dietrich Kluth; Roman Metzger; Holger Till; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2009-06-02       Impact factor: 1.827

4.  Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion.

Authors:  Michael B Sano; Robert E Neal; Paulo A Garcia; David Gerber; John Robertson; Rafael V Davalos
Journal:  Biomed Eng Online       Date:  2010-12-10       Impact factor: 2.819

5.  Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering.

Authors:  Hussamuddin Adwan; Barry Fuller; Clare Seldon; Brian Davidson; Alexander Seifalian
Journal:  J Biomater Appl       Date:  2012-04-24       Impact factor: 2.646

Review 6.  Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory.

Authors:  Henning C Fiegel; Peter M Kaufmann; Helge Bruns; Dietrich Kluth; Raymund E Horch; Joseph P Vacanti; Ulrich Kneser
Journal:  J Cell Mol Med       Date:  2007-11-16       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.